Shock therapy bracelet zaps nausea after surgery
NCT ID NCT06241547
First seen Apr 19, 2026 · Last updated Jun 22, 2026 · Updated 10 times
Summary
This study tested a wearable bracelet that delivers mild electrical stimulation to a point on the wrist (PC6) to prevent nausea and vomiting after laparoscopic surgery. 326 women participated, and the bracelet was used alongside standard anti-nausea drugs. The goal was to see if adding this device reduces nausea in the first 24 hours after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for POSTOPERATIVE NAUSEA AND VOMITING are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Peking Union Medical College Hospital
Beijing, China
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
electrical stimulation via EmeTerm bracelet
What this could lead to
If it works, this could offer a non-drug way to prevent nausea and vomiting after surgery, reducing reliance on antiemetic medications.
What could go wrong
This is a single, completed Phase 2 trial with 326 women. The effect may be modest or not better than standard drugs, and results may not apply to men or other surgeries.
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.